NRAS and melanoma: NRAS Q61R is present in 0.73% of AACR GENIE cases [59], and has been identified in cutaneous melanoma, melanoma, papillary thyroid cancer, poorly differentiated thyroid gland cancer, and colon adenocarcinoma [59].